Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: zurdo who wrote (1908)	5/1/1998 1:14:00 PM
From: Home-Run	Read Replies (1) \| Respond to of 9523

Upgrade info form Yahoo Message Board: <- Previous Next -> Message 4411 of 4438 Reply PFE - Upgraded. Style_J (32/M/Brussels) May 1 1998 10:42AM EDT For your info, briefly, the best banks in belgium for stocks are recommanding PFE as Strong Buy, they say it will be the same success as with zyrtec, the company stock have been multiplied by 5 when zyrtec was released by UCB, belgian pharmaceutical. Here Pfizer will do the same. They think that sale forecasts are underestimated. People are already illegaly importing viagra in other countries, check the online news...

To: zurdo who wrote (1908)	5/1/1998 2:42:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

TOKYO (Nikkei)--An increasing number of Japanese consumers are importing foreign pharmaceutical products that have not been approved in Japan, The Nihon Keizai Shimbun reported in its Friday morning edition. Many drugs to treat hair loss, insomnia or depression that are widely used in the U.S. are still unavailable in Japan. Consumers who learn about the drugs are deluging import agencies with requests for the products, the newspaper said. According to a Tokyo-based company that began importing pharmaceutical and health-food products two years ago, most customers are men in their late 20s or early 30s. Particularly popular items include Rogaine, a Pharmacia & Upjohn Inc. treatment for hair loss, and melatonin, a substance used to combat insomnia. The company has also received a number of inquiries about Merck & Co.'s hair-growth drug Propecia and Pfizer Inc.'s Viagra, an impotence treatment, both hit products in the U.S. Eyeing the increase in Japanese demand, a number of companies advertise such drugs on their Internet homepages, the newspaper said. According to the Health and Welfare Ministry, the importation of pharmaceutical products solely for individual use does not violate the country's Pharmaceutical Affairs Law. Nevertheless, the ministry has begun considering actions such as clamping down on the advertising of unapproved drugs, the newspaper said. A Health and Welfare Ministry official said that if the ministry sees Japanese companies post any information on unapproved drugs on the Internet, it will consider that a violation of the law,' a ministry official. The ministry cannot restrict advertising posted overseas, however. (END) DOW JONES NEWS 04-30-98 12:00 PM